Literature DB >> 1400703

Methylphenidate and cognitive perseveration in hyperactive children.

R Tannock1, R Schachar.   

Abstract

Effects of methylphenidate on cognitive flexibility were investigated in 26 children with Attention Deficit Hyperactivity Disorder (ADHD), by assessing perseverative errors on the Wisconsin Card Sorting Test (WCST) and the emergence of clinical symptoms indicative of cognitive perseveration. A double-blind, placebo-control, randomized crossover design was used in which each child was assessed twice in each drug condition (placebo, 0.3 and 1.0 mg/kg). Results indicated that methylphenidate increased perseverative errors on the first assessment but decreased them on the second; clinical symptoms of perseveration occurred at both assessments. Findings suggest that MPH may reduce cognitive flexibility temporarily in some ADHD children.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1400703     DOI: 10.1111/j.1469-7610.1992.tb00940.x

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  13 in total

Review 1.  Pharmacokinetics and clinical effectiveness of methylphenidate.

Authors:  H C Kimko; J T Cross; D R Abernethy
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

Review 2.  Catecholamine influences on dorsolateral prefrontal cortical networks.

Authors:  Amy F T Arnsten
Journal:  Biol Psychiatry       Date:  2011-04-13       Impact factor: 13.382

3.  Amphetamine Modestly Improves Conners' Continuous Performance Test Performance in Healthy Adults.

Authors:  David A MacQueen; Arpi Minassian; Brook L Henry; Mark A Geyer; Jared W Young; William Perry
Journal:  J Int Neuropsychol Soc       Date:  2017-10-16       Impact factor: 2.892

4.  Differentiation of rodent behavioral phenotypes and methylphenidate action in sustained and flexible attention tasks.

Authors:  Richard Chu; Jed Shumsky; Barry D Waterhouse
Journal:  Brain Res       Date:  2015-12-10       Impact factor: 3.252

5.  Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors.

Authors:  Nao J Gamo; Min Wang; Amy F T Arnsten
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-09-01       Impact factor: 8.829

6.  Methylphenidate and cognitive flexibility: dissociated dose effects in hyperactive children.

Authors:  R Tannock; R Schachar; G Logan
Journal:  J Abnorm Child Psychol       Date:  1995-04

7.  Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatments.

Authors:  Roxann C Harvey; Chloe J Jordan; David H Tassin; Kayla R Moody; Linda P Dwoskin; Kathleen M Kantak
Journal:  Behav Brain Res       Date:  2013-01-31       Impact factor: 3.332

8.  Methylphenidate improves performance on the radial arm maze in periadolescent rats.

Authors:  Diana L Dow-Edwards; Jeremy C Weedon; Esther Hellmann
Journal:  Neurotoxicol Teratol       Date:  2008-04-13       Impact factor: 3.763

9.  Methylphenidate affects task-switching and neural signaling in non-human primates.

Authors:  Abigail Z Rajala; Luis C Populin; Rick L Jenison
Journal:  Psychopharmacology (Berl)       Date:  2020-02-18       Impact factor: 4.530

Review 10.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.